FIBERGRAFT Aeridyan Posterolateral Fusion Study

NANot yet recruitingINTERVENTIONAL
Enrollment

316

Participants

Timeline

Start Date

September 15, 2025

Primary Completion Date

March 1, 2026

Study Completion Date

October 31, 2028

Conditions
Degenerative Spine Disease
Interventions
DEVICE

FIBERGRAFT™ Aeridyan Matrix Bone Graft Substitute

"FIBERGRAFT™ Aeridyan Matrix is a next generation synthetic bone graft that is resorbable, bioactive, and osteoconductive. FIBERGRAFT Aeridyan Matrix is composed of ultra-porous 45S5 bioactive glass granules, boron-based bioactive glass microspheres, and bovine type 1 collagen. The granules are made entirely of 45S5 bioactive glass fibers and feature a porous outer shell encasing an intricate nest of micro- and nano- fibers and microspheres. The nonporous microspheres are made entirely of boron-based bioactive glass and feature essential metallic ions such as zinc, copper, magnesium, and potassium. The highly biocompatible type 1 collagen5 serves as a carrier for the bioactive glass components.~FIBERGRAFT Aeridyan Matrix is designed to have an adequate structural integrity for its application as a bone graft substitute material, while optimizing radiopacity and resorption."

DEVICE

Demineralized Bone Matrix

Demineralized Bone Matrix is to be used with bone marrow aspirate and mixed with autograft bone in accordance with approved indications per the IFU

Trial Locations (7)

19107

Rothman Orthopaedics Institute, Philadelphia

27710

Duke University Medical Center, Durham

40536

UK Health Care Kentucky Neuroscience Institute, Lexington

60612

University Of Illinois, Chicago

77030

UT Health Houston, Houston

95816

UC Davis Health System, Sacramento

02115

Brigham And Women's Hospital, Boston

All Listed Sponsors
lead

DePuy Synthes Products, Inc.

INDUSTRY

NCT07059065 - FIBERGRAFT Aeridyan Posterolateral Fusion Study | Biotech Hunter | Biotech Hunter